Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The hypothesis of this study is that topical cervical and intra-cervical lidocaine will decrease pain associated with the insertion of a Mirena® (levonorgestrel intrauterine device).

1. Primary Aim- Determine if topical lidocaine intra-cervically and on the cervix decreases the pain associated with insertion of a Mirena® (levonorgestrel intrauterine device).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Tennessee
• Treatments: Levonorgestrel; Lidocaine

Criteria

Inclusion Criteria:

1. Any subject receiving a Mirena® (levonorgestrel intrauterine device) for standard indications.

2. Subjects who received nonsteroidal anti-inflammatory drugs (NSAIDS) will not be excluded.

Exclusion Criteria:

1. Subjects do not desire to be involved in the study

2. Subjects who have taken narcotics.

3. If the Mirena® (levonorgestrel intrauterine device) is not able to be successfully placed.

4. If cervical dilation is required, these subjects will be placed in a separate subset and will be reported on separately.

5. Subject has allergy to lidocaine.